Virus Transport Medium
– with flocked swab (optional)
Sample device
Molecular biological assays are performed on the pharyngeal specimen in order to identify clear viral sequences specific to the SARS CoV-2 virus that causes the current COVID-19 epidemic.
A throat swab specimen is taken from the patient, which – in case of an infected patient – contains viruses.The sample is placed in a collection tube, which inactivates the virus, therefore it immediately loses its capability to infect during transport and sample handling, while stabilizing the RNA for up to 96 hours to provide a safer and more efficient workflow for molecular diagnostic purposes, testing and sequencing.
Non-invasive sampling does not require blood taking involved in the process.
The National Institute of Pharmacy and Nutrition hereby certifies, that on the basis of information provided, the medical device(s) names below and detailed in the attachment (if applicable), which is/are manufactured by the above economic operator, has/have been affixed with the CE mark under the Directive 98/79/EC of the European Parliament and of the Council on in vitro diagnostic medical devices and/or the Council Directive 93/42/EEC concerning medical devices (as amended) which was transposed into Hungarian national law (decree No. 8/2003. (III. 13) of the Ministry of Health, Social and Family Affairs on in vitro diagnostic medical devices and/or decree No. 4/2009 (III. 17) of the Ministry of Health on medical devices, as amended, may be freely sold in all member states of the European Economic Area (EEA) including Hungary.